Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Clinical Characterization of a Novel Mutation in SLC25A38 Resulting in Congenital Sideroblastic Anemia in a Canadian First Nations Population

Kelsey Uminski, MD BSc, Donald S. Houston, MD PhD, Jessica Hartley, MS, CGC, Geoffrey Cuvelier, MD, Sara J. Israels, MD

Blood (2018) 132 (Supplement 1): 1035.

https://doi.org/10.1182/blood-2018-99-110343

Published: 2018

Journal Articles

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

Cesar O Pezina Cantú, MD, Perla R. Colunga Pedraza, MD, Andres Gomez De Leon, MD, Diana E Garcia-Camarillo, MD, Oscar Marquez-Pinedo, MD, Paola Santana-Hernandez, MD, Olga Cantu Rodriguez, MD, Cesar Homero Gutierrez Aguirre, MD, Luz del Carmen Tarín Arzaga, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 1043.

https://doi.org/10.1182/blood-2018-99-118611

Published: 2018

Journal Articles

A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion

Parth Desai, MD MBBS, Annapurna Saksena, MD MBBS, Prasad Sudhir Dange, Richa Gupta, Seema Kapoor, Tejinder Singh

Blood (2017) 130 (Supplement 1): 4958.

https://doi.org/10.1182/blood.V130.Suppl_1.4958.4958

Published: 2017

Journal Articles

Clinico-Pathological Features and Outcomes in Patients with Congenital Sideroblastic Anemias

Leah Ann Schmelkin, BS, Matthew T Howard, MD, David P. Steensma, MD, Mark D. Fleming, MD DPhil, Vilmarie Rodriguez, MD, Shakila Khan, MD, Naseema Gangat, MBBS, Alexandra Wolanskyj, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 3355.

https://doi.org/10.1182/blood.V126.23.3355.3355

Published: 2015

Journal Articles

A New Mutation Of The ALAS2 Gene In a Chinese Family With X-linked

Rui Cui, MD, Guoqing Zhu, Zefeng Xu, Yue Zhang, MD, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2013) 122 (21): 4674.

https://doi.org/10.1182/blood.V122.21.4674.4674

Published: 2013

Journal Articles

Pharmacokinetics of Dasatinib in a Patient with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Treatment with Anti-Tuberculosis Therapy

Michelle P. Zeller, MD, Jan H Beumer, Pharm. D., Ph.D., Susan M Christner, B.S., Anargyros Xenocostas, MD, FRCPC

Blood (2011) 118 (21): 5006.

https://doi.org/10.1182/blood.V118.21.5006.5006

Published: 2011

Journal Articles

Lack of Efficacy of Pyridoxine (Vitamin B6) Treatment In Acquired Idiopathic Sideroblastic Anemia, Including Refractory Anemia with Ring Sideroblasts

Lisa M Baumann Kreuziger, MD, Alexandra Wolanskyj, MD, David P. Steensma, MD

Blood (2010) 116 (21): 2919.

https://doi.org/10.1182/blood.V116.21.2919.2919

Published: 2010

Journal Articles

Low Ascorbate Levels in Transfused Patients Are Associated with Correlates of Vascular Damage in Sickle Cell Disease.

Susan Claster, MD, Susan Carson, Thomas C Hofstra, MD, Thomas Coates, John C Wood

Blood (2009) 114 (22): 2570.

https://doi.org/10.1182/blood.V114.22.2570.2570

Published: 2009

Journal Articles

New Mutation in ALAS2 as the Cause of X-Linked Sideroblastic Anemia Responsive to Pyridoxine: Comparison of ALAS2-Defective and DMT1-Defective BFU-E Growth.

Jana Kucerova, MSc, Monika Horvathova, MSc, PhD, Petra Belohlavkova, MD, Jaroslav Cermak, M.D., Ph.D., Vladimir Divoky, PhD

Blood (2009) 114 (22): 4051.

https://doi.org/10.1182/blood.V114.22.4051.4051

Published: 2009

Journal Articles

A NOVEL Mutation of the Erythroid-Specific Aminolevulinate Synthase 2 Gene IN A Patient with Pyridoxine Responsive Sideroblastic Anemia and Deferasirox Responsive Hemochromatosis.

Umran Caliskan, Huseyin Tokgoz, Hasan Yuksekkaya

Blood (2009) 114 (22): 5105.

https://doi.org/10.1182/blood.V114.22.5105.5105

Published: 2009

Journal Articles

Hereditary Spherocytosis (HS) Associated with a Heterozygous MTHFR C677T Mutation and with Elevated Anticardiolipin Antibodies.

Luis S. Noble, MD, Maria Velazquez, MD, Anuradha Gupta, MD, Mark M. Landeros, Juan Herrada, MD

Blood (2009) 114 (22): 5069.

https://doi.org/10.1182/blood.V114.22.5069.5069

Published: 2009

Journal Articles

Sequential Administration of Bortezomib, Liposomal Doxorubicin and Dexamethasone (BDD) Followed by Thalidomide and Dexamethasone (TD) Results in Rapid Control of Untreated High-Risk Multiple Myeloma (MM) and Improves Depth of Response

Heather Landau, MD, Hani Hassoun, MD, Adam Cohen, MD, Elizabeth Hoover, Tarun Kewalramani, MD, Adam Boruchov, MD, Virginia Klimek, MD, Lillian Reich, MD, Elyn Riedel, Neeta Pandit-Taskar, MD, Stephen D. Nimer, MD, Raymond L. Comenzo, MD

Blood (2008) 112 (11): 3712.

https://doi.org/10.1182/blood.V112.11.3712.3712

Published: 2008

Journal Articles

Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis (RARS-t): A Clinicopathological Entity with Questionable Pathogenesis

Anupma Nayak, MD, Abha Goyal, MD, Judith Brody, MD, Peihong Hsu, MD, PhD, Steven Savona, Rita Weiss, George Zervos

Blood (2008) 112 (11): 5252.

https://doi.org/10.1182/blood.V112.11.5252.5252

Published: 2008

Journal Articles

Pegylated Liposomal Doxorubicin in Primary Cutaneous Lymphomas: Efficacy, Safety, and Low Rate of Palmar-Plantar Erythrodysesthesia

Stefano Pulini, Serena Rupoli, Nicola Pimpinelli, Annalisa Natale, Gaia Goteri, Anna Rita Scortechini, Paola Picardi, Simonetta Mulattieri, Pietro Leoni, Giuseppe Fioritoni

Blood (2008) 112 (11): 4932.

https://doi.org/10.1182/blood.V112.11.4932.4932

Published: 2008

Journal Articles

X-Linked Sideroblastic Anemia Is a Rare Cause of Microcytosis and Iron Overload in Adults: About 3 Cases with 2 New ALAS2 Gene Mutations Improved after Iron Chelation by Phlebotomy.

Mohamed Touati, Franck Trimoreau, Marie-Pierre Gourin-Chaury, Caroline Kannengiesser, Pascal Turlure, Veronique Loustaud-Ratti, Brigitte Gilbert-Dussardier, Bernard Grandchamp, Dominique Bordessoule

Blood (2007) 110 (11): 4619.

https://doi.org/10.1182/blood.V110.11.4619.4619

Published: 2007

Journal Articles

Severe Sideroblastic Anaemia in an ALAS2 Compound Heterozygote for −206G, a Common Polymorphism, and a Novel Mutation in Exon 11 (Lys535del) Linked to Lack of Haemoglobinisation In Vitro and Ineffective Erythropoiesis In Vivo.

Alison May, PhD, Carol Barton, FRCPath, Gillian Masters, MA, Jeanne Kingston, BSc, Sue Lawless, MSc, Michael Jenner, MRCPath

Blood (2005) 106 (11): 3541.

https://doi.org/10.1182/blood.V106.11.3541.3541

Published: 2005

Journal Articles

Acquired Sideroblastic Anaemia Unresponsive to Pyridoxine Caused by a Somatic Mutation in ALA Synthase 2.

Alison May, PhD, Ala I. Al-Sabah, MRCPath, Susan L. Lawless, MSc

Blood (2005) 106 (11): 3542.

https://doi.org/10.1182/blood.V106.11.3542.3542

Published: 2005

Journal Articles

Thrombohemorrhagic Defects and Recurrent Miscarriage Syndrome.

Rodger L. Bick, M.D., Ph.D., Deborah. Hoppensteadt, Ph.D

Blood (2004) 104 (11): 2602.

https://doi.org/10.1182/blood.V104.11.2602.2602

Published: 2004

Journal Articles

Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A First Randomised, Placebo-Controlled, Double-Blind Trial.

Gerard M.J. Bos, MD, PhD, Martin Heijer den, MD, PhD, Huub Willems, MD, Henk Blom, PhD, Wim Gerrits, MD, Marco Cattaneo, MD, Sabine Eichinger, MD, Frits Rosendaal, MD

Blood (2004) 104 (11): 489.

https://doi.org/10.1182/blood.V104.11.489.489

Published: 2004

Journal Articles

A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia

Soumeya Bekri, Alison May, Philip D. Cotter, Ala I. Al-Sabah, Xiaojun Guo, Gillian S. Masters, David F. Bishop

Blood (2003) 102 (2): 698–704.

https://doi.org/10.1182/blood-2002-06-1623

Published: 2003

NARROW

Clinical Characterization of a Novel Mutation in SLC25A38 Resulting in Congenital Sideroblastic Anemia in a Canadian First Nations Population

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion

Clinico-Pathological Features and Outcomes in Patients with Congenital Sideroblastic Anemias

A New Mutation Of The ALAS2 Gene In a Chinese Family With X-linked

Pharmacokinetics of Dasatinib in a Patient with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Treatment with Anti-Tuberculosis Therapy

Lack of Efficacy of Pyridoxine (Vitamin B6) Treatment In Acquired Idiopathic Sideroblastic Anemia, Including Refractory Anemia with Ring Sideroblasts

Low Ascorbate Levels in Transfused Patients Are Associated with Correlates of Vascular Damage in Sickle Cell Disease.

New Mutation in ALAS2 as the Cause of X-Linked Sideroblastic Anemia Responsive to Pyridoxine: Comparison of ALAS2-Defective and DMT1-Defective BFU-E Growth.

A NOVEL Mutation of the Erythroid-Specific Aminolevulinate Synthase 2 Gene IN A Patient with Pyridoxine Responsive Sideroblastic Anemia and Deferasirox Responsive Hemochromatosis.

Hereditary Spherocytosis (HS) Associated with a Heterozygous MTHFR C677T Mutation and with Elevated Anticardiolipin Antibodies.

Sequential Administration of Bortezomib, Liposomal Doxorubicin and Dexamethasone (BDD) Followed by Thalidomide and Dexamethasone (TD) Results in Rapid Control of Untreated High-Risk Multiple Myeloma (MM) and Improves Depth of Response

Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis (RARS-t): A Clinicopathological Entity with Questionable Pathogenesis

Pegylated Liposomal Doxorubicin in Primary Cutaneous Lymphomas: Efficacy, Safety, and Low Rate of Palmar-Plantar Erythrodysesthesia

X-Linked Sideroblastic Anemia Is a Rare Cause of Microcytosis and Iron Overload in Adults: About 3 Cases with 2 New ALAS2 Gene Mutations Improved after Iron Chelation by Phlebotomy.

Severe Sideroblastic Anaemia in an ALAS2 Compound Heterozygote for −206G, a Common Polymorphism, and a Novel Mutation in Exon 11 (Lys535del) Linked to Lack of Haemoglobinisation In Vitro and Ineffective Erythropoiesis In Vivo.

Acquired Sideroblastic Anaemia Unresponsive to Pyridoxine Caused by a Somatic Mutation in ALA Synthase 2.

Thrombohemorrhagic Defects and Recurrent Miscarriage Syndrome.

Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A First Randomised, Placebo-Controlled, Double-Blind Trial.

A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only